Cartigenix HP® is clinically shown to support cartilage regeneration, joint flexibility, and comfort by targeting the structural foundation of joint health. We create products without parallel, going beyond relief to support the fundamental elements of joint health.*†
Cartigenix HP is backed by three published human trials with significant beneficial results. One prospective study and two randomized, placebo-controlled human trials demonstrated significant improvements in mobility, comfort, and cartilage regeneration.* Results of taking the supplement were reported in as little as 15 days, with statistically significant improvements at 90 days.†
Clinically Studied Benefits
- Supports cartilage regeneration*
- Helps maintain joint comfort and mobility*
- Supports comfortable daily exercise*
- Helps reduce exercise-related stiffness and improve movement comfort*
Restore What Moves You
Movement isn’t just physical; it’s emotional. It’s freedom, connection, independence. Whether it’s walking the dog or getting back to what you love, joint discomfort shouldn’t be what holds you back.
Who is Cartigenix HP for?
- People who experience joint stiffness or discomfort
- Active adults seeking to maintain healthy movement and mobility
- Anyone wanting a clinically supported, proactive approach to joint and cartilage health
Suggested Use: Take 2 capsules daily, one in the morning, and one in the evening, with a meal, or as directed by your healthcare practitioner.
Serving Size: 2 Capsules
Amount Per Serving:
Proprietary RestorCel™ blend containing … 1100 mg
Indian frankincense (Boswellia serrata) [gum] extract, Apium graveolens L. (seed) extract.
Other ingredients: Hypromellose (capsule), microcrystalline cellulose.
Made without gluten, dairy or soy. Vegan. Non-GMO.
Warnings: Keep out of reach of children. If you are pregnant, nursing, have a medical condition, or taking prescription medications, consult your healthcare practitioner prior to use.
†As shown in two placebo-controlled, randomized, controlled human research studies (Vaidya 2025; Desai 2024). A prospective study (n=1,236) similarly demonstrated significant improvements in pain scores, along with quality of life measures (Desai 2022).
*These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease.
